A multi-disciplinary team of senior physicians opted to use Zidebactam/Cefepime under compassionate use
Phase 3 study results will form the basis for future discussions with global regulatory authorities
ALS is a rare, progressive and fatal neurodegenerative disease, with an average life expectancy of 3 to 5 years from the time of symptom onset
First and only long-acting C5 complement inhibitor offers patients with AQP4 Ab+
GC1130A has previously achieved notable milestones by securing both RPDD and ODD from the U.S. FDA in January 2023
Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country
Pheezee is designed to assess musculoskeletal and neuromuscular health.
All children (100%) in the presymptomatic intravenous cohort of LT-002 maintained or achieved all assessed motor milestones, including independent walking
ANSSI Wellness launches Asia’s premier and USA-patented ‘Spinal Decompression Treatment’ center in Nashik
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
Subscribe To Our Newsletter & Stay Updated
